澳大利亚全科医生对风险定制癌症筛查的接受度:一项定性研究
该研究通过半结构化访谈20名澳大利亚全科医生,探讨其对风险定制癌症筛查的接受度及实施障碍。结果显示,全科医生原则上接受该理念,但担忧筛查建议变化引起困惑、低风险者减少筛查频率或排除出项目难以接受,并指出缺乏高质量证据、担心漏诊及时间不足等障碍。研究建议制定循证指南、开展专业教育、开发风险计算器及针对性公众信息以提高可行性。
要点
- 全科医生原则上接受风险定制筛查,但担忧筛查建议变化引起困惑。
- 低风险者减少筛查频率或排除出项目,尤其常见癌症,初期可能不被接受。
- 实施障碍包括缺乏高质量证据、担心漏诊、时间不足及教育方式不明确。
核心结论
- 全科医生目前可能尚未确信风险定制筛查的净获益。
- 制定可及的循证指南、专业教育、风险计算器和针对性公众信息将提高其在全科实践中的可行性。
研究设计与样本
- 定性研究,采用半结构化访谈,对象为澳大利亚全科医生。
- 访谈录音并转录,数据先归纳分析再演绎分析,使用实施框架。
- 共纳入20名参与者(n=20)。
主要发现
- 参与者认为风险定制筛查原则上可接受,认可对最高风险者增强筛查的潜在益处。
- 参与者显著担忧筛查建议变化可能引起困惑。
- 对低风险者减少筛查频率或排除出筛查项目,尤其常见癌症且筛查微创时,初期可能不被接受。
- 其他保留意见包括缺乏高质量获益证据、担心漏诊癌症迹象或症状、与患者时间不足。
- 未确定单一首选的专业教育方式,但围绕沟通筛查结果和风险分层的教育被认为重要。
临床怎么用
- 全科医生应关注风险定制筛查的循证指南和专业教育,以支持共同决策。
- 使用风险计算器辅助风险分层,并重视沟通筛查结果和风险的教育。
- 针对低风险者减少筛查频率或排除出项目时,需考虑患者接受度和针对性公众信息。
局限性
- 定性研究,样本为20名澳大利亚全科医生,结果可能不具广泛代表性。
- 未确定单一首选的专业教育方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cancer screening that is tailored to individual risk has the potential to improve health outcomes and reduce screening-related harms, if implemented well. However, successful implementation depends on acceptability, particularly as this approach will require GPs to change their practice. AIM: To explore Australian GPs' views about the acceptability of risk-tailored screening across cancer types and to identify barriers to and facilitators of implementation. DESIGN AND SETTING: A qualitative study using semi-structured interviews with Australian GPs. METHOD: Interviews were carried out with GPs and audio-recorded and transcribed. Data were first analysed inductively then deductively using an implementation framework. RESULTS: Participants (n = 20) found risk-tailored screening to be acceptable in principle, recognising potential benefits in offering enhanced screening to those at highest risk. However, they had significant concerns that changes in screening advice could potentially cause confusion. They also reported that a reduced screening frequency or exclusion from a screening programme for those deemed low risk may not initially be acceptable, especially for common cancers with minimally invasive screening. Other reservations about implementing risk-tailored screening in general practice included a lack of high-quality evidence of benefit, fear of missing the signs or symptoms of a patient's cancer, and inadequate time with patients. While no single preferred approach to professional education was identified, education around communicating screening results and risk stratification was considered important. CONCLUSION: GPs may not currently be convinced of the net benefits of risk-tailored screening. Development of accessible evidence-based guidelines, professional education, risk calculators, and targeted public messages will increase its feasibility in general practice.
引用
- Dunlop KLA, Smit AK, Keogh LA, et al. Acceptability of risk-tailored cancer screening among Australian GPs: a qualitative study. Br J Gen Pract. 2024. PMID: 38373853. doi:10.3399/BJGP.2023.0117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。